Vireo Growth (VREOF) Change in Intangibles (2022)

Vireo Growth (VREOF) reported Change in Intangibles of $236635.0 for Q1 2022.

Vireo Growth (VREOF) Change in Intangibles (2022) Analysis & Trends

Vireo Growth (VREOF) has 1 years of Change in Intangibles data on file, last reported at $236635.0 in Q1 2022.

  • For the quarter ending Q1 2022, Change in Intangibles changed N/A year-over-year to $236635.0; the trailing twelve-month figure through Dec 2022 stood at $236635.0 (changed N/A YoY), and the FY2022 full-year result was $236635.0, changed N/A from the prior year.
  • Change in Intangibles steadied at $236635.0 in Q1 2022.
  • In the past five years, Change in Intangibles ranged from a high of $236635.0 in Q1 2022 to a low of $236635.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Haleon 89.69 Bn 87.82 Bn - -
2 Teva Pharmaceutical Industries 35.84 Bn 32.10 Bn 1.97 Bn -
3 Zoetis 32.67 Bn 30.73 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.69 Bn 23.63 Bn 4.39 Bn -107.94 Mn
5 United Therapeutics 23.12 Bn 20.97 Bn 648.10 Mn -
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.24 Bn 18.44 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.83 Bn 16.51 Bn 800.70 Mn -
9 Elanco Animal Health 12.64 Bn 12.22 Bn 785.00 Mn -
10 Vireo Growth 10.52 Bn 10.37 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 236,635.00
Mar 31, 2022 236,635.00